Exposure to childhood infections and risk of Epstein-Barr virus-defined Hodgkin's lymphoma in women

International Journal of Cancer

Volumn 115, Issue 4, 2005, Pages 599-605

  Glaser, Sally L ^a   Keegan, Theresa H M ^a   Clarke, Christina A ^a   Trinh, Muoi ^a   Dorfman, Ronald F ^b   Mann, Risa B ^c   DiGiuseppe, Joseph A ^d   Ambinder, Richard F ^c  

^a NORTHERN CALIFORNIA CANCER CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d HARTFORD HOSPITAL   (United States)

Author keywords

Epstein Barr virus; Etiology; Hodgkin's lymphoma; Infectious mononucleosis; Risk factor

Indexed keywords

ADULT; AGED; ARTICLE; CHILDHOOD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EPSTEIN BARR VIRUS; FAMILY HISTORY; FEMALE; HODGKIN DISEASE; HUMAN; IN SITU HYBRIDIZATION; INFECTION; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SOCIAL CLASS; UNITED STATES; VIRUS DETECTION; VIRUS INFECTION;

ADULT; AGED; ANIMALS; CALIFORNIA; CASE-CONTROL STUDIES; CHILD; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; INCIDENCE; INFECTION; RISK;

EID: 18544364772     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20787     Document Type: Article

References (48)

1. MacMahon B. Epidemiological evidence on the nature of Hodgkin's disease. Cancer 1957;10:1045-54.
2. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966;26:1189-201.
3. Gutensohn N, Cole P. Epidemiology of Hodgkin's disease in the young. Int J Cancer 1977;19:595-604.
4. Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. New Engl J Med 1981;304:135-40.
5. Mueller N. Hodgkin's disease. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996.893-919.
6. Mueller N, Grufferman S. The epidemiology of Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's disease Philadelphia: Lippincott Williams & Wilkins, 1999.61-77.
7. Ambinder RF, Weiss LM. Association of Epstein-Barr virus with Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's disease. Philadelphia: Lippincott Williams & Wilkins, 1999.79-98.
8. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, O'Grady J, Hummel M, Preciado MV, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997;70:375-82.
9. Flavell KJ, Biddulph JP, Constandinou CM, Lowe D, Scott K, Crocker J, Young LS, Murray PG. Variation in the frequency of Epstein-Barr virus-associated Hodgkin's disease with age. Leukemia 2000;14:748-53.
10. Jarrett RF, Krajewski AS, Angus B, Freeland J, Taylor PR, Taylor GM, Alexander FE. The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates. J Clin Pathol 2003;56:811-6.
11. Sleckman BG, Mauch PM, Ambinder RF, Mann R, Pinkus GS, Kadin ME, Sherburne B, Perez-Atayde A, Thior I, Mueller N. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev 1998;7:1117-21.
12. Flavell K, Constandinou C, Lowe D, Scott K, Newey C, Evans D, Dutton A, Simmons S, Smith R, Crocker J, Young LS, Murray P. Effect of material deprivation on Epstein-Barr virus infection in Hodgkin's disease in the west Midlands. Br J Cancer 1999;80:604-8.
13. Alexander FE, Jarrett RF, Lawrence D, Armstrong AA, Freeland J, Gokhale DA, Kane E, Taylor GM, Wright DH, Cartwright RA. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. Br J Cancer 2000;82:1117-21.
14. + HD in young adults. Int J Cancer 2003;107:298-302.
15. Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang JS, Madsen M, Rosdahl N, Konradsen HB, Storm HH, Melbye M. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 2003;349:1324-32.
16. Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF. Reproductive risk factors in Hodgkin's disease in women. Am J Epidemiol 2003;158:553-63.
17. Glaser SL, Stearns CB. Reliability of random-digit dialing screening calls to enumerate an adult female population. Am J Epidemiol 2002;155:972-5.
18. Murray PG, Constandinou CM, Crocker J, Young LS, Ambinder RF. Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease. Blood 1998;92:2477-83.
19. Gulley ML, Glaser SL, Craig FE, Borowitz MD, Mann RB, Shema SJ, Ambinder RF. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin's disease. Am J Clin Pathol 2002;117:259-67.
20. Glaser SL, Clarke CA, Nugent RA, Steams CB, Dorfman RF. Social class and risk of Hodgkin's disease in young-adult women in 1988-94. Int J Cancer 2002;98:110-17.
21. Glaser SL, Clarke CA, Stearns CB, Dorfman RF. Age variation in Hodgkin's disease risk factors in older women: evidence from a population-based case-control study. Leuk Lymphoma 2001;42:997-1004.
22. Glaser SL, Keegan THM, Clarke CA, Darrow L, Gomez SL, Dorfman RF, Mann RB, DiGiuseppe JA, Ambinder RF. Smoking and Hodgkin's disease risk in women. Cancer Causes Control 2004;15:387-97.
23. Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, Brown I, Lee F, Kane E, Jarrett RF. Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 1998;12:1272-6.
24. Stoopler MB, Caldwell GG, Zack MM, Housworth WJ, Heath CWJ. Sibship size and Hodgkin's disease. N Engl J Med 1975;292:1025-8.
25. Paffenbarger RS Jr, Wing AL, Hyde RT. Characteristics in youth indicative of adult-onset Hodgkin's disease. J Natl Cancer Inst 1977;58:1489-91.
26. Vianna NJ, Polan AK. Immunity in Hodgkin's disease: importance of age at exposure. Ann Intern Med 1978;89:550-6.
27. Abramson JH, Pridan H, Sacks MI, Avitzour M, Peritz E. A case-control study of Hodgkin's disease in Israel. J Natl Cancer Inst 1978;61:307-14.
28. Bernard SM, Cartwright RA, Darwin CM, Richards ID, Roberts B, O'Brien C, Bird CC. Hodgkin's disease: case control epidemiological study in Yorkshire. Br J Cancer 1987;55:85-90.
29. Westergaard T, Melbye M, Pedersen JB, Frisch M, Olsen JH, Andersen PK. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer 1997;72:977-81.
30. Hsu JL, Glaser SL. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Hematol Oncol 2000;34:27-53.
31. Gutensohn NM. Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the "two-disease hypothesis". Cancer Treat Rep 1982;66:689-95.
32. Andersen E, Isager H. Pre-morbid factors in Hodgkin's disease. II. BCG-vaccination status, tuberculosis, infectious diseases, tonsillectomy, and appendectomy. Scand J Haematol 1978;21:273-7.
33. Bernard SM, Cartwright RA, Bird CC, Richards ID, Lauder I, Roberts BE. Aetiologic factors in lymphoid malignancies: a case-control epidemiological study. Leuk Res 1984;8:681-9.
34. Serraino D, Franceschi S, Talamini R, Barra S, Negri E, Carbone A, La Vecchia C. Socio-economic indicators, infectious diseases and Hodgkin's disease. Int J Cancer 1991;47:352-7.
35. Vineis P, Crosignani P, Sacerdote C, Fontana A, Masala G, Miligi L, Nanni O, Ramazzotti V, Rodella S, Stagnaro E, Tumino R, Vigano C, et al. Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health 2000;54:431-6.
36. Tavani A, La Vecchia C, Franceschi S, Serraino D, Carbone A. Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev 2000;9:59-64.
37. Becker N, Deeg E, Nieters A. Population-based study of lymphoma in Germany: rationale, study design and first results. Leuk Res 2004;28:713-24.
38. National Immunization Program. Epidemiology and prevention of vaccine-preventable diseases: the pink book, 8th ed. Atlanta: Centers for Disease Control and Prevention, 2004.
39. Evans AS, Kaslow RA. Viral infections of humans: epidemiology and control, 4th ed. New York: Plenum, 1997.
40. Purtilo DT, Sakamoto K. Reactivation of Epstein-Barr virus in pregnant women: social factors, and immune competence as determinants of lymphoproliferative diseases - a hypothesis. Med Hypotheses 1982;8:401-8.
41. Sakamoto K, Greally J, Gilfillan RF, Sexton J, Barnabei V, Yetz J, Bechtold T, Seeley JK, O'Dwyer E, Purtilo DT. Epstein-Barr virus in normal pregnant women. Am J Reprod Immunol 1982;2:217-21.
42. Gallagher A, Perry J, Shield L, Freeland J, MacKenzie J, Jarrett RF. Viruses and Hodgkin disease: no evidence of novel herpesviruses in non-EBV-associated lesions. Int J Cancer 2002;101:259-64.
43. National Cancer Institute. SEER*Stat 5.1.14 with 1973-2000 cancer incidence data. Silver Spring, MD: Information Management Services, 2004.
44. Hjalgrim H, Askling J, Sorensen P, Madsen M, Rosdahl N, Storm HH, Hamilton-Dutoit S, Eriksen LS, Frisch M, Ekbom A, Melbye M. Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J Natl Cancer Inst 2000;92:1522-8.
45. Helminen M, Lahdenpohja N, Hurme M. Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. J Infect Dis 1999;180:496-9.
46. Helminen ME, Kilpinen S, Virta M, Hurme M. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 2001;184:777-80.
47. Clarke CA, Glaser SL, Dorfman RF, Mann R, DiGiuseppe JA, Prehn AW, Ambinder RF. Epstein-Barr virus and survival after Hodgkin's disease in a population-based series of women. Cancer 2001;91:1579-87.
48. Lin AY, Kingma DW, Lennette ET, Fears TR, Whitehouse JM, Ambinder RF, Jaffe ES, Levine PH, Tucker MA. Epstein-Barr virus and familial Hodgkin's disease. Blood 1996;88:3160-5.